Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Effector Therapeutics

Explore full profile

Development of small molecule cancer therapeutics

San Diego, United StatesFounded 2012Biotech & Life Sciences
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Effector Therapeutics and the history behind them.

About Effector Therapeutics

eFFECTOR Therapeutics is a biotechnology company specializing in the discovery and development of selective translation regulator inhibitors, a novel class of small molecule drugs. These inhibitors target the process of protein synthesis at the translation level, aiming to treat various diseases, including cancer and viral infections. The company's flagship product, zotatifin, is currently being tested in patients with solid tumors and has shown promising in vitro antiviral activity against SARS-CoV-2, the virus responsible for COVID-19. eFFECTOR primarily serves the healthcare and pharmaceutical markets, focusing on patients with unmet medical needs. The business model revolves around research and development, clinical trials, and eventual commercialization of its drug candidates. Revenue is generated through partnerships, grants, and future sales of approved therapies.

Source: Dealroom company data

At a glance

Founded
2012
Headquarters
San Diego, United States
Sector
Biotech & Life Sciences

Latest news

Press, funding announcements and product moves mentioning Effector Therapeutics.

See all news

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A11 investors entered at this stage

  • Mission Bay Capital
  • Abingworth
  • U.S. Venture Partners
  • Osage University Partners
  • SR One
  • Astellas Venture
  • Novartis Venture Fund
  • Altitude Life Science Ventures
  • Abbvie Biotech Ventures
  • The Column Group
  • Sectoral Asset Management

Series B and later4 investors entered at this stage

  • Pfizer
  • BioMed Ventures
  • Alexandria Venture Investments
  • Locust Walk Acquisition

Talent

Book a demo to see the people
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Diego HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Effector Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Effector Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles